PFO
BLFS icon

Pathstone Family Office’s BioLife Solutions BLFS Stock Holding History

Pathstone Family Office’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$298K Buy
21,605
+838
+4% +$13.2K ﹤0.01% 1312
2023
Q2 		$480K Hold
20,767
– – 0.01% 763
2023
Q1 		$475K Buy
+20,767
New +$467K 0.01% 715

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Pathstone Family Office's BLFS Position: Q3 2023 in Review

Pathstone Family Office increased its BioLife Solutions (BLFS) stake by 4% in Q3 2023, buying an estimated $13.2K and bringing the position to 21,605 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

Pathstone Family Office first reported a position in BLFS in Q1 2023 and has held it in 3 quarters since. The position peaked at $480K in Q2 2023. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • Pathstone Family Office held 21,605 shares of BioLife Solutions worth $298K as of Q3 2023.
  • Pathstone Family Office bought 838 BioLife Solutions shares in Q3 2023, an estimated $13.2K.
  • BioLife Solutions made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1312 holding.
  • Pathstone Family Office first reported a position in BioLife Solutions in Q1 2023 and has held it in 3 quarters since.
  • Pathstone Family Office's BioLife Solutions position peaked at $480K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.